Investing
Plexāā, maker of the Bloom medical device for breast surgery, scores $4.5 million in funding.
The company offers mental healthcare for children and their families and will use the funds to expand its reach.
The company offers an AI-enabled workflow automation platform for administrative tasks pertaining to specialty medications.
The company will use the funds to hasten product development, engineering and go-to-market efforts to meet market demand.
The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.
The Series E funding comes four months after the company secured $250 million in a Series D round.
Funding from the venture capital firm's Customer Value Fund will allow Commure to accelerate its expansion in healthcare without ownership dilution.
The funding comes on the heels of the fax automation company's $37 million Series B funding round and $18 million Series A raise last year.
In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.
Lyrebird Health plans to scale its operation internationally, beginning in the United Kingdom.